ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382

ClinicalTrials.gov ID: NCT06032546

Public ClinicalTrials.gov record NCT06032546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 10:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living With HIV on Stable Antiretroviral Therapy Undergoing Analytical Treatment Interruption

Study identification

NCT ID
NCT06032546
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
163 participants

Conditions and interventions

Interventions

  • ABBV-382 Drug
  • Budigalimab Drug
  • Placebo for ABBV-382 Drug
  • Placebo for Budigalimab Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 11, 2023
Primary completion
Sep 21, 2025
Completion
Sep 21, 2025
Last update posted
Oct 28, 2025

2023 – 2025

United States locations

U.S. sites
43
U.S. states
15
U.S. cities
36
Facility City State ZIP Site status
University of Alabama at Birmingham, 1917 Research Clinic /ID# 257549 Birmingham Alabama 35222-2309
Franco Felizarta, Md /Id# 256927 Bakersfield California 93301
AHF Research Center /ID# 257025 Beverly Hills California 90211
Long Beach Education and Research Consultants /ID# 257552 Long Beach California 90813-3267
AHF Healthcare Center- Hollywood /ID# 257026 Los Angeles California 90027
Los Angeles LGBT Center /ID# 258407 Los Angeles California 90028-6213
Ruane Clinical Research Group /ID# 256932 Los Angeles California 90036
Palmtree Clinical Research Inc. /Id# 258409 Palm Springs California 92262
Optimus Medical /ID# 257182 San Francisco California 94102
Quest Clinical Research /ID# 256928 San Francisco California 94115-3037
Washington Health Institute /ID# 259336 Washington D.C. District of Columbia 20017
Midland Florida Clinical Research Center /ID# 257101 DeLand Florida 32720-0920
AIDS Healthcare Foundation (AHF) - Healthcare Center - Northpoint /ID# 256934 Fort Lauderdale Florida 33308
Midway Immunology and Research Center /ID# 256930 Ft. Pierce Florida 34982
Advanced Pharma CR, LLC /ID# 259335 Miami Florida 33147
Orlando Immunology Center /ID# 256931 Orlando Florida 32803
Bliss Health /ID# 257827 Orlando Florida 32806-3300
Baycare Medical Group - Tampa /ID# 256953 Tampa Florida 33614
The Pierone Research Institute /ID# 257022 Vero Beach Florida 32960-6541
Triple O Research Institute /ID# 256929 West Palm Beach Florida 33407
Winship At Emory University Hospital Midtown /ID# 258410 Atlanta Georgia 30308
Metro Infectious Disease Consultants, P.L.L.C /ID# 256955 Decatur Georgia 30033
Howard Brown Health Center /ID# 257485 Chicago Illinois 60613-2010
Claudia T. Martorell MD LLC dba The Research Institute /ID# 259155 Springfield Massachusetts 01105-1406
KC CARE Health Center - Midtown South /ID# 257178 Kansas City Missouri 64111
Las Vegas Research Center /ID# 257619 Las Vegas Nevada 89106
Cooper University Health Care - Camden /ID# 258133 Camden New Jersey 08103
Saint Michael's Medical Center /ID# 258802 Newark New Jersey 07102
South Jersey Infectious Disease /ID# 257840 Somers Point New Jersey 08244
Unmhsc /Id# 257533 Albuquerque New Mexico 87102-2612
Suny Upstate University Hospital Community Campus /ID# 257847 Syracuse New York 13215
Jacobi Medical Center /ID# 257849 The Bronx New York 10461
Montefiore Medical Center /ID# 257792 The Bronx New York 10467
East Carolina University - Brody School of Medicine /ID# 257544 Greenville North Carolina 27834
Atrium Health Wake Forest Baptist Medical Center /ID# 257542 Winston-Salem North Carolina 27157
Central Texas Clinical Research /ID# 256920 Austin Texas 78705-3326
Prism Health North Texas - Oak Cliff Health Center /ID# 256933 Dallas Texas 75208-4599
North Texas Infectious Diseases Consultants, P.A /ID# 257592 Dallas Texas 75246
University of Texas Southwestern Medical Center /ID# 257551 Dallas Texas 75390-7208
Texas Center for Infectious Disease Associates /ID# 257183 Fort Worth Texas 76104
The Crofoot Research Center, Inc /ID# 256921 Houston Texas 77098-3900
DCOL Center for Clinical Research /ID# 257093 Longview Texas 75605
Wisconsin Medical Center /ID# 257498 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06032546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06032546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →